Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
     
.
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools

InteliHealth Policies
Site Map

   Advertisement
carepass Ad
carepass Ad .
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Health News Health News
.
Health News
333
Medications
Panel: Thumbs Down on Anthrax Vaccine Test in Kids
Panel: Thumbs Down on Anthrax Vaccine Test in Kids
apdigital_2013_03_19_ap.online.health-medical_DA53U60G1_news_ap_org.anpa
WASHINGTON (AP) -- Don't look for testing of the anthrax vaccine to begin in children any time soon.
1482555
InteliHealth
2013-03-19
t
Associated Press
2013-04-18
Associated Press

Panel: Thumbs Down on Anthrax Vaccine Test in Kids
March 19, 2013

WASHINGTON (AP) -- Don't look for testing of the anthrax vaccine to begin in children any time soon.

Controversy arose last year as experts debated whether such studies should be done to learn how to treat children in case of a bioterror attack.

But a presidential commission says the government would have to take multiple steps -- including more safety research in young adults -- before it would be ethical to consider tests in children.

"The safety of our children is paramount, and we have to get this precisely right," said Dr. Amy Gutmann, who chairs the Presidential Commission for the Study of Bioethical Issues, which released its report Tuesday.

More than a decade after the anthrax attacks, the government has a multibillion-dollar stockpile of drugs and vaccines to fight an array of threats. There's no information on whether those so-called countermeasures would work in children like they're expected to help their parents, or even what dose to use. Yet if a large attack were to occur, children undoubtedly would receive those untested products.

Worried about how to handle an emergency, a government advisory group recommended studying the anthrax vaccine in children if independent ethics experts agreed it could be done appropriately. The Obama administration put that question to the panel.

Tuesday's answer: Children don't gain any benefit from pre-attack research with the anthrax vaccine or other countermeasures. So the panel said such studies would be ethical only if they presented no more than minimal risk to participants -- like the risk from a routine medical check-up. Determining that would require, among other things, more testing in adults, the panel added. Something that proved safe in 18-year-olds, for example, might be a candidate to study next in 16- and 17-year-olds.

However, the government should plan now for how it would study children who receive those treatments in the event of an attack, the panel said.

The Department of Health and Human Services, which requested the advice, said it would review the findings.

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
General Health
Top News
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Environmental Health
Eyes
Family Health
Fitness
Genetics
Headache
Health Policy
HIV / AIDS
Heart Health
Lung Cancer
Medications
Infectious Diseases
Men's Health
Nutrition News
Mental Health
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
anthrax
21291
.
.  
This website is certified by Health On the Net Foundation. Click to verify.
.
Chrome 2001
Chrome 2001